black forest glp 1 plot from meta-analysis models of GLP-1 RA's impact on (a) HbA1c Frontiers | GLP1 receptor agonists

Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts

Maintaining Vascular Balance (The NO System) Beyond direct growth, BPC-157 acts as a sophisticated moderator for Nitric Oxide (NO), the gas the body uses to relax blood vessels and direct blood flow to an injury

When to stay at a lower dose If you are losing weight steadily at your current dose and tolerating it well, there is no medical reason to increase

And as a consequence, some impact mood and libido and others don't